L02BB06 darolutamide
ATC group of level 5 – chemical substance · in plain English: hormone treatment of cancer
This site has the patient leaflet or the SPC of 1 medicine in this group.
- 1 prescription only (POM)
Active substance: Darolutamide – all medicines with this substance, also in combinations.
Place in the ATC classification
How to read ATC codes – what the levels mean and what a code does not tell you.
- L Antineoplastic and immunomodulating agents 1,791 medicines
- L02 Endocrine therapy antineoplastic and immunomodulating agents 131 medicines
- L02B Hormone antagonists and related agents 87 medicines
- L02BB Anti-androgen hormone antagonists and related agents 21 medicines
- L02BB06 darolutamide 1 medicine
- L02BB Anti-androgen hormone antagonists and related agents 21 medicines
- L02B Hormone antagonists and related agents 87 medicines
- L02 Endocrine therapy antineoplastic and immunomodulating agents 131 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Nubeqa 300 mg film-coated tablets SPC | Prescription only (POM) |
Other groups of the same level
- L02BB01 flutamide 2 medicines
- L02BB03 bicalutamide 7 medicines
- L02BB04 enzalutamide 9 medicines
- L02BB05 apalutamide 2 medicines
Other names of the ATC group
- Spanish: L02BB06 Darolutamida
- German: L02BB06 Darolutamid
- Italian: L02BB06 DAROLUTAMIDE
- Turkish: L02BB06 darolutamid
- German (Switzerland): L02BB06 Darolutamid
- French (Switzerland): L02BB06 Darolutamide
- Italian (Switzerland): L02BB06 Darolutamide
- English (Canada): L02BB06 Darolutamide
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L02BB06
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.